JP-1366 20mg Versus Esomeprazole 40mg in Patients With Erosive Esophagitis

NCT05443984 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

300

Enrollment

INDUSTRY

Sponsor class

Conditions

Erosive Esophagitis

Interventions

DRUG: JP-1366 20mg
DRUG: Esomeprazole 40mg

Sponsor

Onconic Therapeutics Inc.